共 93 条
[1]
Hughes RAC(2005)Joint Task Force of the EFNS and the PNS: European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy J Peripher Nerv Syst 10 220-8
[2]
Bouche P(2009)Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy J Neurol Sci 277 1-8
[3]
Cornblath DR(2009)Incidence and prevalence of CIDP and the association of diabetes mellitus Neurology 73 39-45
[4]
Evers E(2006)Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy J Peripher Nerv Syst 11 30-46
[5]
Hadden RD(2008)Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy J Immunol 181 8753-60
[6]
Hahn A(2001)P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy Ann. Neurol. 50 286-92
[7]
Koski CL(2009)Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy J. Neurol. Neurosurg. Psychiatry 80 333-8
[8]
Baumgarten M(1997)Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy J. Neuroimmunol. 73 124-34
[9]
Magder LS(2005)Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes Nat. Clin. Pract. Neurol. 1 2-3
[10]
Barohn RJ(2001)Sural nerve T-cell receptor Vbeta gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy Neurology 56 74-81